Total Number of Communication Reports: 0
Monthly communication reports in the last 6 months: 0
Version 6 of 11 (2007-06-05 to 2008-04-28) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
Consultant lobbyist name: | ADRIENNE BLANCHARD Lobbyist business address |
Consulting firm: |
GOWLING LAFLEUR HENDERSON LLP
160 ELGIN STREET OTTAWA, ON K1P 1C3 Canada |
Position: | LAWYER |
Telephone number: | 613-233-1781 |
Fax number: | 613-563-9869 |
Former public office holder: | Yes |
Payment is contingent on the success of the undertaking: | No |
Client: |
CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX&D)
1220 - 55 METCALFE STREET OTTAWA, ON K1P 6L5 Canada |
Telephone number: | 613-236-0455 |
Fax number: | 613-236-7919 |
Client Representative: |
RUSSELL
WILLIAMS
|
Parent: | The client is not a subsidiary of any other parent companies. |
Coalition: | The client is not a coalition. |
Subsidiary: | The client does not have any subsidiaries that could be affected by the outcome of the undertaking. |
Individual, organization or corporation: | The client's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
Was the client funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Health Canada (HC), Industry Canada, MEMBERS OF PARLIAMENT, Patented Medicine Prices Review Board (PMPRB) | ||||||||
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format | ||||||||
Subject Matter: Areas of Concern: | Canada's Access to Medicines Regime, Health, Industry, Intellectual Property | ||||||||
Details Regarding the Identified Subject Matter
|